# Optimization of HIV-1 DNA Genotyping by High Throughput Sequencing to Document Antiretroviral Resistant Mutations

> **NCT03512795** · — · COMPLETED · sponsor: **Centre Hospitalier Universitaire Dijon** · enrollment: 71 (actual)

## Conditions studied

- HIV-1-infection

## Interventions

- **BIOLOGICAL:** Blood samples

## Key facts

- **NCT ID:** NCT03512795
- **Lead sponsor:** Centre Hospitalier Universitaire Dijon
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-08
- **Primary completion:** 2020-03-05
- **Final completion:** 2020-03-05
- **Target enrollment:** 71 (ACTUAL)
- **Last updated:** 2024-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03512795

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03512795, "Optimization of HIV-1 DNA Genotyping by High Throughput Sequencing to Document Antiretroviral Resistant Mutations". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT03512795. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*